TRIPLE HELIX BIOTECHNOLOGY LTD
Company number 13749240 · Monitor this company
Executive summary
Triple Helix Biotechnology Ltd is a start-up biotech company with a stable but modest asset base and low liabilities. The company is currently loss-making with a significant drop in cash reserves over the past year, highlighting liquidity risk. Credit approval is conditional on continued monitoring of cash flow, profitability improvements, and management’s ability to secure additional funding to support ongoing operations.
Shareholders' funds
£299,950
Balance sheet as at 2024-11-30
What it does
72110 - Research and experimental development on biotechnology
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-11-17
- Employees
- 2 (2024 accounts)
- Registered office
- 12 New Fetter Lane, London, United Kingdom, EC4A 1JP
- Postcode
- EC4A 1JP
- Capital
- 150 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2024-11-30
- Next due by
- 2026-11-30
- Financial year end
- 30 November
Confirmation statement
- Last statement dated
- 2025-11-16
- Next due by
- 2026-11-30
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current
Among its peers
Top 25%
by shareholders' funds, of 138 similar companies in EC
Trading since 2021.
Competitors London
This company ranks 23 among research and experimental development on biotechnology in London.